ME
MediPharm Labs Corp.
MEDIF · OTC
$0.05 +4.31% (+$0.00)
1M -10.02%
Market Cap $30.7M
P/E Ratio -
Div. Yield -
ROE 13.79%
Bulios Fair Price
$0.06
12.8% upside
Trenutna cena
$0.053
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MEDIF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.87x
P/S 0.74x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 13.87%
Rev. growth 26.80%
FCF growth N/A
Profitability
13 /100
Weak Net margin 11.99%
Op. margin 12.21%
FCF margin 2.22%
Quality
11 /100
Poor ROE 13.79%
ROA 10.81%
Asset turnover 0.90x
Debt
69 /100
Low Current ratio 2.69x
Int. coverage -80.62x
Debt/Equity 0.01x
Stability
62 /100
Moderate Rev. volatility 21.04%
EPS volatility 23.97%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MEDIF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Greg Hunter
Employees
127
Headquarters
Barrie
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report